Momose Isao

モモセイサオ | Momose Isao

Affiliation and department：
Job title： Chief Researcher
Homepage URL (1)： http://www.bikaken.or.jp/

Research field (3)： Pharmaceuticals - health and biochemistry , Environmental and pharmaceutical development resources , Chemical biology

Research keywords (4)：天然物化学 , 応用微生物学・応用生物化学 , Natural Product Chemistry , Drug Development

Research theme for competitive and other funds (10)：

2022 - 2025 細胞膜リン脂質リモデリングを標的とした新規抗がん剤の創出
2020 - 2023 Development of comprehensive cancer immunotherapy using metabolism inhibitors
2019 - 2022 乳がんにおけるc-Mycと合成致死作用を示す新たな抗がん剤の創出
2015 - 2018 Elucidation of androgen-dependent growth inhibition mechanism in prostate cancer of novel small molecule compound APA
2014 - 2018 がん特異的代謝機構に基づいた抗腫瘍薬の開発と応用

Show all

Papers (47)：

Yuji Kubota, Yuko Fujioka, Ashwini Patil, Yusuke Takagi, Daisuke Matsubara, Masatomi Iijima, Isao Momose, Ryosuke Naka, Kenta Nakai, Nobuo N. Noda, et al. Qualitative differences in disease-associated MEK mutants reveal molecular signatures and aberrant signaling-crosstalk in cancer. Nature Communications. 2022. 13. 1
Yohko Yamazaki, Hikaru Abe, Chiharu Sakashita, Shun-Ichi Ohba, Takumi Watanabe, Isao Momose, Manabu Kawada. Author Correction: Androprostamine A: a unique antiprostate cancer agent (The Journal of Antibiotics, (2021), 74, 10, (717-725), 10.1038/s41429-021-00449-8). Journal of Antibiotics. 2021. 74. 10. 767
Daisuke Tatsuda, Masahide Amemiya, Ryuichi Sawa, Isao Momose, Manabu Kawada. Quinofuracins F - I, new quinofuracin derivatives produced by Staphylotrichum boninense PF1444. Journal of Antibiotics. 2021. 74. 10. 758-762
Yohko Yamazaki, Hikaru Abe, Chiharu Sakashita, Shun-Ichi Ohba, Takumi Watanabe, Isao Momose, Manabu Kawada. Androprostamine A: a unique antiprostate cancer agent. Journal of Antibiotics. 2021. 74. 10. 717-725
Isao Momose, Takefumi Onodera, Manabu Kawada. [Potential Anticancer Activity of Auranofin]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 2021. 141. 3. 315-321

ｍore...

MISC (1)：

久保田裕二, 藤岡優子, 高木祐輔, 松原大祐, 飯島正富, 百瀬功, 中井謙太, 野田展生, 武川睦寛. Elucidation of molecular mechanisms of ERK hyper-activation and drug-resistance in cancers with MEK1 mutations. 日本癌学会学術総会抄録集(Web). 2022. 81st

Professional career (1)：

Work history (2)：

Committee career (2)：

Association Membership(s) (4)：

THE JAPANESE ASSOCIATION FOR MOLECULAR TARGET THERAPY OF CANCER , 日本癌学会 , 日本放線菌学会 , 日本農芸化学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page